文献速递心力衰竭与心肌病心律失常冠心病

意大利北部COVID-19合并心脏病住院患者的特征与结局

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.
PubMed 文献 · Eur Heart J · 2020-01-01

心脏病患者死亡率更高(36% vs. 15%,log-rank P=0.019;相对风险2.35;95%CI 1.08-5.09),血栓栓塞事件和脓毒性休克发生率也更高。

要点

  • 合并心脏病史的COVID-19住院患者死亡率显著高于无心脏病史者(36% vs. 15%)。
  • 心脏病患者血栓栓塞事件(23% vs. 6%)和脓毒性休克(11% vs. 0%)发生率更高。
  • 心脏病患者血清肌酐、NT-proBNP和高敏肌钙蛋白T水平更高。

核心结论

  • 合并心脏病史的COVID-19住院患者预后极差,死亡率、血栓栓塞事件和脓毒性休克发生率均显著高于无心脏病史者。

主要发现

  • 心脏病患者中40%有心力衰竭史,36%有心房颤动史,30%有冠心病史。
  • 总体住院期间26%死亡,15%发生血栓栓塞事件,19%发生急性呼吸窘迫综合征,6%发生脓毒性休克。
  • 心脏病患者死亡率36%,无心脏病史者15%(log-rank P=0.019;相对风险2.35;95%CI 1.08-5.09)。
  • 心脏病患者血栓栓塞事件发生率23% vs. 6%,脓毒性休克发生率11% vs. 0%。
  • 心脏病患者血清肌酐、N末端脑钠肽前体和高敏肌钙蛋白T水平更高。

临床怎么用

  • 对合并心脏病史的COVID-19住院患者应加强监测,警惕高死亡风险、血栓栓塞事件和脓毒性休克。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To compare demographic characteristics, clinical presentation, and outcomes of patients with and without concomitant cardiac disease, hospitalized for COVID-19 in Brescia, Lombardy, Italy. METHODS AND RESULTS: The study population includes 99 consecutive patients with COVID-19 pneumonia admitted to our hospital between 4 March and 25 March 2020. Fifty-three patients with a history of cardiac disease were compared with 46 without cardiac disease. Among cardiac patients, 40% had a history of heart failure, 36% had atrial fibrillation, and 30% had coronary artery disease. Mean age was 67 ± 12 years, and 80 (81%) patients were males. No differences were found between cardiac and non-cardiac patients except for higher values of serum creatinine, N-terminal probrain natriuretic peptide, and high sensitivity troponin T in cardiac patients. During hospitalization, 26% patients died, 15% developed thrombo-embolic events, 19% had acute respiratory distress syndrome, and 6% had septic shock. Mortality was higher in patients with cardiac disease compared with the others (36% vs. 15%, log-rank P = 0.019; relative risk 2.35; 95% confidence interval 1.08-5.09). The rate of thrombo-embolic events and septic shock during the hospitalization was also higher in cardiac patients (23% vs. 6% and 11% vs. 0%, respectively). CONCLUSIONS: Hospitalized patients with concomitant cardiac disease and COVID-19 have an extremely poor prognosis compared with subjects without a history of cardiac disease, with higher mortality, thrombo-embolic events, and septic shock rates.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020. PMID: 32383763. doi:10.1093/eurheartj/ehaa388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。